A molecular detection kit for hepatic abscess-causing Klebsiella pneumoniae and its application
A technology of Klebsiella pneumoniae and detection kit, which is applied in the field of disease diagnosis to achieve the effect of improving the success rate of treatment
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0033] Development and validation of specific sequences:
[0034]The screening process of specific gene sequences combines the next-generation sequencing technology (Next-Generation Sequencing, NGS), comparative genomics (Comparative Genomics) and bioinformatics (Bioinformatics) methods, and uses scientific statistical methods to analyze sequences in multiple The specificity of the distribution in the Klebsiella pneumoniae genome was tested, and PCR validation was performed in the isolated Klebsiella pneumoniae and non-hepatoabscess Klebsiella pneumoniae to determine the sequence in Klebsiella pneumoniae. Specificity in Lebsiella. The specific implementation process is as follows:
[0035] Two strains of Klebsiella pneumoniae and one strain of Klebsiella pneumoniae isolated from mainland China were selected for whole-genome sequencing, and the sequencing results were spliced by SPAdes (v3. Analysis platform for gene prediction and functional annotation. The obtained seque...
Embodiment 2
[0043] Gene-specific verification:
[0044] The specific steps for the verification of pagO and luxR-induced liver abscess Klebsiella pneumoniae-specific genes in clinical isolates are as follows:
[0045] 1. Select clinically isolated hepatic abscess and non-hepatic abscess Klebsiella pneumoniae bacterial strains for detection of pagO (shown in SEQ ID N O.1) and luxR (shown in SEQ ID NO.2) in causing hepatic abscess pneumonia Specificity in Klebsiella. 40 strains of Klebsiella pneumoniae isolated from the abscess of patients with liver abscess were selected as the detection group (hepatic abscess group), and 36 strains of Klebsiella pneumoniae isolated from non-Klebsiella pneumoniae patients with liver abscess were selected as negative controls group (non-hepatic abscess-induced group). At the same time, other common pathogenic bacteria (other pathogenic bacteria groups) isolated clinically were also selected to further verify the specificity of these factors in Klebsiella ...
Embodiment 3
[0061] Application of pagO and luxR sequences or primers designed based on the sequences in the preparation of Klebsiella pneumoniae liver abscess diagnostic kit:
[0062] The design idea of this experiment is as follows: the clinically obtained blood culture samples are divided into a blood culture positive group and a healthy person negative group, where the blood culture positive group refers to all samples with bacteria cultured in the blood, not limited to the blood cultured with pneumonia. Lebsiella, including cultures of other pathogenic bacteria. Use PCR to detect the presence of specific factors (i.e. pagO and luxR) in the positive blood culture sample and the negative blood culture sample, and finally analyze the corresponding analysis of the PCR result and the patient's final clinical diagnosis, so as to judge that the method provided by the present invention is effective against pneumonia. Detection rate of Lebsiella liver abscess.
[0063] 1. Collection of clin...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com